Didanosine

Back to search

Molecule Structure

Scientific Name

Didanosine

Description of the Drug

Didanosine is a reverse transcriptase inhibitor used to treat HIV.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00900

Brand Name(s)

Didanosine, Videx, Videx ec

Company Owner(s)

Bristol Myers Squibb Co, Aurobindo Pharma Ltd, Mylan Pharmaceuticals Inc, Barr Laboratories Inc, Bristol Myers Squibb Co Pharmaceutical Research Institute, Bristol-Myers Squibb Co

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Human immunodeficiency virus type 1 reverse transcriptase SINGLE PROTEIN INHIBITOR CHEMBL247

Unichem Links

SureChEMBL SCHEMBL3363
PharmGKB PA449301
Human Metabolome Database HMDB0015037
DrugBank DB00900
PubChem: Thomson Pharma 15121788 15121787 14847321 15196316
PubChem 135398739
Mcule MCULE-2844514954
LINCS LSM-6017
Nikkaji J261.930J
PDBe 2DI
BindingDB 50404252
EPA CompTox Dashboard DTXSID6022927
DrugCentral 869
Brenda 148764 1813 51621 124179 14441
ChemicalBook CB0680765
Guide to Pharmacology 4833
rxnorm VIDEX VIDEX EC DIDANOSINE
PubChem: Drugs of the Future 12014245
KEGG Ligand C06953
ChEBI 490877
ZINC ZINC000013597823